Compare XBIT & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | KSCP |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | 85 | N/A |
| Industry | Pharmaceuticals and Biotechnology | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.0M | 58.1M |
| IPO Year | 2015 | 2022 |
| Metric | XBIT | KSCP |
|---|---|---|
| Price | $2.43 | $3.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 42.9K | ★ 812.3K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.54 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,335,000.00 |
| Revenue This Year | N/A | $152.93 |
| Revenue Next Year | N/A | $94.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.91 |
| 52 Week Low | $2.09 | $2.92 |
| 52 Week High | $3.61 | $10.13 |
| Indicator | XBIT | KSCP |
|---|---|---|
| Relative Strength Index (RSI) | 56.48 | 46.93 |
| Support Level | $2.15 | $3.41 |
| Resistance Level | $2.46 | $4.50 |
| Average True Range (ATR) | 0.07 | 0.48 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 70.83 | 19.14 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.